The analysis of pulmonary tromboembolism (PTE) in structure of mortality of therapeutic and surgical patients

Y. Mostovoy, T. Konstantinovich (Vinnitsa, Ukraine)

Source: Annual Congress 2007 - Venous thromboembolic disease
Session: Venous thromboembolic disease
Session type: Thematic Poster Session
Number: 3554
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Mostovoy, T. Konstantinovich (Vinnitsa, Ukraine). The analysis of pulmonary tromboembolism (PTE) in structure of mortality of therapeutic and surgical patients. Eur Respir J 2007; 30: Suppl. 51, 3554

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Accuracy of pre-operative specimen level prediction in chronic thromboembolic pulmonary hypertension (CTEPH) patients undergoing pulmonary thromboendarterectomy (PTE)
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development
Source: Eur Respir J 2003; 22: Suppl. 45, 221s
Year: 2003

Analysis of long-term survival of patients diagnosed of pulmonary embolism (PE)
Source: Annual Congress 2006 - Pulmonary embolism
Year: 2006


Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy
Source: Annual Congress 2004 - Pulmonary embolism
Year: 2004


Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009

Recurrence and bleeding in the extended treatment of patients with pulmonary embolism (PE) and cancer
Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism
Year: 2018

Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)?
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

Predictive value of CT pulmonary angiography to assess surgical accessibility for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension (CTEPH) patients
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


The effect of pulmonary thromboendarterectomy (PTE) on dead space ventilation in patients with chronic thrombo embolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2004; 24: Suppl. 48, 404s
Year: 2004

Initial dual oral combination therapy prior to pulmonary endarterectomy (PEA) in patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) and high preoperative pulmonary vascular resistance (PVR)
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 58 (6) 2100699; 10.1183/13993003.00699-2021
Year: 2021



Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF)
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018



Internal validation of a model to predict the risk of short-term (10 days) adverse outcomes in patients with pulmonary embolism (PE)
Source: Annual Congress 2006 - Pulmonary embolism
Year: 2006


The use of pulmonary embolism severity index (PESI) score in identifying patients suitable for ambulatory treatment or early hospital discharge following diagnosis of pulmonary embolism
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012


Prognostic value of the ECG on admission in patients with acute major pulmonary embolism
Source: Eur Respir J 2005; 25: 843-848
Year: 2005



A risk score of adverse short-term clinical outcomes in patients with acute pulmonary embolism (PE)
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005

Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 263-271
Year: 2015



Predicting short-term mortality in patients with pulmonary embolism: A simple model
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018